884PReal-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). (23rd October 2018) - Procopio, G; Bamias, A; Schmidinger, M; Hawkins, R; Rodriguez Sanchez, A; Vazquez, S; Srihari, N; Kalofonos, H; Bono, P; Pisal, C; Hirschberg, Y; Dezzani, L; et al.